Quantitative analysis for Rigel Pharmaceuticals Inc. Common Stock (RIGL) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (61.0) (grade B). 23 signals analyzed (18 differentiated alt-data).
RIGL stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-09 | $30.61 | $29.08 | $30.51 |
| 2026-04-21 | $32.71 | $32.00 | $32.29 |
| 2026-05-01 | $29.59 | $28.79 | $29.40 |
| 2026-05-13 | $33.01 | $29.66 | $32.13 |
| 2026-05-26 | $29.34 | $28.51 | $29.17 |
| 2026-06-05 | $30.69 | $29.74 | $29.93 |
| 2026-06-17 | $34.39 | $32.71 | $33.37 |
| 2026-06-30 | $40.20 | $38.72 | $39.12 |
| 2026-07-13 | $42.85 | $40.77 | $41.30 |
| 2026-07-23 | $38.00 | $36.54 | $36.82 |
| 2026-08-04 | $39.45 | $37.70 | $38.70 |
| 2026-08-14 | $42.69 | $40.54 | $42.58 |
How Rigel Pharmaceuticals Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
Rigel Pharmaceuticals Inc. Common Stock (RIGL) scores Buy (61.0), with no measured dimension below 47. Its highest are technicals at 96, competitive moat at 82, analyst consensus at 68, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 96 |
| competitive moat | 82 |
| analyst consensus | 68 |
| earnings quality | 52 |
| valuation | 47 |
StoQuant analyzes 23 signals (18 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Rigel Pharmaceuticals Inc. Common Stock (RIGL): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/RIGL"><img src="https://stoquant.com/badge/RIGL.svg" alt="Rigel Pharmaceuticals Inc. Common Stock (RIGL) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Daily Q-Score changes, insider buy clusters, and ML forecast updates for the tickers you follow. Email only, no account needed. See a sample digest.